BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24710190)

  • 1. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
    Yan S; Qu X; Xu L; Che X; Ma Y; Zhang L; Teng Y; Zou H; Liu Y
    Anticancer Drugs; 2014 Jul; 25(6):683-9. PubMed ID: 24710190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
    Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts.
    Xu L; Hu X; Qu X; Hou K; Zheng H; Liu Y
    Biochem Biophys Res Commun; 2013 Sep; 439(2):285-90. PubMed ID: 23973713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells.
    Ouyang W; Yang C; Liu Y; Xiong J; Zhang J; Zhong Y; Zhang G; Zhou F; Zhou Y; Xie C
    Int J Oncol; 2011 Dec; 39(6):1577-86. PubMed ID: 21769428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts.
    Xu L; Qu X; Luo Y; Zhang Y; Liu J; Qu J; Zhang L; Liu Y
    Mol Med Rep; 2011; 4(3):407-11. PubMed ID: 21468584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.
    Ouyang W; Yang C; Zhang S; Liu Y; Yang B; Zhang J; Zhou F; Zhou Y; Xie C
    Int J Oncol; 2013 Feb; 42(2):699-711. PubMed ID: 23258590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism.
    Maldonado-Celis ME; Bousserouel S; Gossé F; Lobstein A; Raul F
    Biochem Biophys Res Commun; 2009 Oct; 388(2):372-6. PubMed ID: 19666002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y; Zhang B
    Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.
    Liu Y; Chen L; Gong Z; Shen L; Kao C; Hock JM; Sun L; Li X
    Oncotarget; 2015 Feb; 6(5):3055-70. PubMed ID: 25605010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
    Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
    Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.
    Xu L; Qu X; Zhang Y; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
    FEBS Lett; 2009 Mar; 583(5):943-8. PubMed ID: 19223002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis.
    Aroui S; Brahim S; Hamelin J; De Waard M; Bréard J; Kenani A
    Apoptosis; 2009 Nov; 14(11):1352-65. PubMed ID: 19731037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.
    Vondálová Blanárová O; Jelínková I; Szöor A; Skender B; Soucek K; Horváth V; Vaculová A; Andera L; Sova P; Szöllosi J; Hofmanová J; Vereb G; Kozubík A
    Carcinogenesis; 2011 Jan; 32(1):42-51. PubMed ID: 21037225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
    Portanova P; Notaro A; Pellerito O; Sabella S; Giuliano M; Calvaruso G
    Int J Oncol; 2013 Jul; 43(1):121-30. PubMed ID: 23686163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies.
    Marconi M; Ascione B; Ciarlo L; Vona R; Garofalo T; Sorice M; Gianni AM; Locatelli SL; Carlo-Stella C; Malorni W; Matarrese P
    Cell Death Dis; 2013 Oct; 4(10):e863. PubMed ID: 24136227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.